This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jul. 5, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel



Finding clues to Alzheimer's in DNA
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In what's being described as the largest, most complete genetic mapping project for a single disease, scientists announced a plan to obtain the genetic makeup of more than 800 individuals enrolled in an Alzheimer's research study. The research will determine all 6 billion letters in each individual's DNA. The new data may explain how genes cause changes in the body that lead people to develop Alzheimer's disease. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.

Method improves genome sequencing accuracy
Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have published results of experiments that demonstrate the power of so-called single-molecule sequencing, which was recently introduced but whose use has so far been limited by technical issues. The team has developed a software package that corrects a serious problem inherent in the newest sequencing technology: the fact that every fifth or sixth DNA "letter" it generates is incorrect. More

Skin lotion modifies your genes
Popular Science    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Future genetic therapy could be as simple as applying a topical lotion, with nanoscale compounds soaking through your epidermis to tweak your DNA. This new class of nucleic acid structures could guard against some types of skin cancer, according to researchers at Northwestern University. More


Your patient's blood doesn't tell you that they will get tired walking the dog. Or that they've had heartburn for the past 2 weeks. But it can tell you whether or not obstructive CAD is what's causing their symptoms. You may not need to go deeper than the blood to know what's happening. MORE

Scientists develop gene therapy alternative, simpler HIV treatment
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists at The Scripps Research Institute have discovered a surprisingly simple and safe method to disrupt specific genes within cells. The scientists highlighted the medical potential of the new technique by demonstrating its use as a safer alternative to an experimental gene therapy against HIV infection. More

 Biotech/Diagnostics/Personalized Medicine

Personalized cancer care promising for young Hodgkin's patients
University of Alabama at Birmingham    Share    Share on FacebookTwitterShare on LinkedinE-mail article
More long-term research on personalized cancer care for children with low-risk Hodgkin's lymphoma is needed, according to University of Alabama at Birmingham scientists who commented in the Journal of the American Medical Association on a study that examined the consequences of adjusted radiation and chemotherapy for the disease. More

1 in 4 couples share HPV strains
MyHealthNewsDaily via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The human papillomavirus spreads surprisingly quickly between two people in a new relationship, a new study finds. In fact, couples in the study were actually more likely to be infected with the same strain or strains of HPV if they had been together less than one year, as opposed to a longer period, the researchers said. More


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

Court allows payment for bone marrow; Should people sell parts?
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
How much would it take for you to consider selling your bone marrow? An appeals court puts the price at about $3,000 in a ruling that now makes it legal to pay donors for their bone marrow tissue. The court's decision may well help thousands of sick patients who need bone marrow transplants to survive, but it also begs the question, what other body parts might next be up for sale? More

Related: Roberts' MDS highlights need for minority donors (MedPage Today)

Family: Stem cell therapy helped blind boy with cerebral palsy
The Detroit News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A year ago, 9-year-old Kaden Strek, of St. Clair Shores, Mich., couldn't see most colors. Born several months premature, he suffered a severe brain bleed as an infant and was later diagnosed with spastic diplegic cerebral palsy and blindness. Now, a year after receiving eight cord blood stem cell infusions in China, Kaden can see not only primary colors but pastels. More

 Emerging Medical Technologies

Court ruling benefits most healthcare firms, could hurt device makers
The Associated Pres via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hospitals, drugmakers and biotech companies are expected to be flush with new customers because of the healthcare law's requirement most Americans have insurance by 2014 or pay a fine. It's unclear if medical device makers will get the same jump in business, and they'll be paying new taxes. For medical device makers, the bad news is they'll have to start paying a 2.3 percent tax beginning in January on sales of devices such as pacemakers and CT scan machines. More

A life vest for cardiac arrest
Medgadget    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Post-cardiac arrest brain damage is a problem that seems to be at least somewhat effectively ameliorated by cooling the body of the patient as soon as possible to around 91 degrees. Researchers at Germany's Hohenstein Institute have developed a vest that, once put on a patient, can deliver rapid cooling. More

 Managed Healthcare News

After healthcare ruling come doubts some states can meet deadlines
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
With the Supreme Court upholding President Obama's landmark healthcare law, debate has shifted to whether deadlines key to the law's goal of expanding coverage to tens of millions of Americans will be pushed back. Some say states and the federal government are facing such complex technical and political realities that some deadlines need to be relaxed. More

California patients struggle to transition to managed care system
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One year ago, California began moving certain Medi-Cal patients into a managed healthcare system with the goal of saving money while better coordinating treatment. But for some of these low-income seniors and disabled patients, the transition has been anything but smooth, forcing severely ill patients to give up their doctors, delay treatment and travel long distances for specialty care. More

 FDA: New Treatments and Technology

Congress OKs plan to combat drug shortages
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As part of what probably will be the only major piece of healthcare legislation to get through Congress in a heated election year, House and Senate lawmakers have approved a plan to mandate early warnings from drugmakers about possible shortages of crucial medications. More

GlaxoSmithKline settles healthcare fraud case for $3 billion
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials described as the largest case of healthcare fraud in U.S. history. The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke U.S. laws in the marketing and development of pharmaceuticals. More

"Bone marrow donors between the ages of 18 and 44 are generally preferred, according to the National Bone Marrow Donor Program. Research shows cells from younger donors lead to more successful transplants."

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 28, 2012
June 21, 2012
June 14, 2012
June 7, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063